Media Summary: CDER's Director of Division of Clinical Compliance Evaluation Ni A. Khin, M.D. defines good clinical practice ( CDER's Deputy Center Director for Clinical Science Robert J. Temple, M.D., shares case studies and FDA Jean Mulinde from CDER's Office of Scientific Investigations describes the casic characteristics of clinical trials of quality.
Data Integrity From International Perspectives 2of11 Gcp Data Integrity Workshop - Detailed Analysis & Overview
CDER's Director of Division of Clinical Compliance Evaluation Ni A. Khin, M.D. defines good clinical practice ( CDER's Deputy Center Director for Clinical Science Robert J. Temple, M.D., shares case studies and FDA Jean Mulinde from CDER's Office of Scientific Investigations describes the casic characteristics of clinical trials of quality. Cynthia F. Kleppinger from CDER's Office of Scientific Investigations describes what a CDER's Director of the Division of Generic Drug Bioequivalence Evaluation Seongeun (Julia) Cho discusses bioequivalence ... Stacey Bruzzese welcomes back Chris Wubbolt, Principal of QACV Consulting, to the show. Today, Stacey and Chris will be ...
Jean Mulinde from CDER's Office of Scientific Investigations and Gail Francis from MHRA helps participants understand 1) the ... Phillip D. Kronstein from CDER's Good Clinical Practice Assessment Branch provides a case study when a sponsor submitted an ... On October 20, 2017, Regis Technologies hosted a Oct 1, 2013 Presenter: Philip Koompan Host: FAA Software and Digital Systems Research Federal Aviation Administration (2 ... GxP-CC equips pharmaceutical and health sciences companies to comply with a complex array of regulations and quality ... MHRA's Operations Manager GLPMA & Laboratories Group Stephen Vinter discusses ICH E6 (R2) and how well designed and ...
Nilufer Tampal, PhD, Acting Deputy Director of the Office of Bioequivalence, discusses the FDA's bioequivalence
